Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 401–500 of 1,000
Epigenetic Alterations in Human Pluripotent Stem Cells: A Tale of Two Cultures
Wutz, A. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.06.012 · Cited by 33
Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells
Trevisan, M., Desole, G., Costanzi, G., Lavezzo, E., Palù, G., & Barzon, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010206 · Cited by 32
Cutting-edge platforms in cardiac tissue engineering
Fleischer, S., Feiner, R., & Dvir, T. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.05.008 · Cited by 33
Identification of small-molecule ion channel modulators in C. elegans channelopathy models
Jiang, Q., Li, K., Lu, W.-J., Li, S., Chen, X., Liu, X., Yuan, J., Ding, Q., Lan, F., & Cai, S. (2018) · Nature Communications · doi:10.1038/s41467-018-06514-5 · Cited by 33
Shah, D., Prajapati, C., Penttinen, K., Cherian, R. M., Koivumäki, J. T., Alexanova, A., Hyttinen, J., & Aalto-Setälä, K. (2020) · Cells · doi:10.3390/cells9051153 · Cited by 31
“Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have been shown to recapitulate disease phenotypes of inherited cardiac diseases such as long QT syndrome and catecholamine polymorphic ventricular tachycardia (CPVT) [24–29].”
BackgroundMura, M., Mehta, A. K., Ramachandra, C. J. A., Zappatore, R., Pisano, F., Ciuffreda, M. C., Barbaccia, V., Crotti, L., Schwartz, P. J., SHIM, W. S. N., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.04.038 · Cited by 31
Building a new strategy for treating heart failure using Induced Pluripotent Stem Cells
Miyagawa, S., & Sawa, Y. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.05.002 · Cited by 32
Ovics, P., Regev, D., Baskin, P., Davidor, M., Shemer, Y., Neeman-Egozi, S., Ben‐Haim, Y., & Binah, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197320 · Cited by 36
Long QT syndrome – Bench to bedside
Ponce‐Balbuena, D., & Deschênes, I. (2021) · Heart Rhythm O2 · doi:10.1016/j.hroo.2021.01.006 · Cited by 32
Cell Sheet‐Based Cardiac Tissue Engineering
Matsuura, K., Masuda, S., & Shimizu, T. (2013) · The Anatomical Record · doi:10.1002/ar.22834 · Cited by 35
The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment
Acab, A., & Muotri, A. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0354-x · Cited by 33
Stem cells: The growing pains of pluripotency
Hayden, E. C. (2011) · Nature · doi:10.1038/473272a · Cited by 39
Personalized Medicine: Genetic Diagnosis for Inherited Cardiomyopathies/Channelopathies
Ackerman, M. J., Marcou, C. A., & Tester, D. J. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.12.010 · Cited by 36
Novel Insights into Disease Modeling Using Induced Pluripotent Stem Cells
Egashira, T., Yuasa, S., & Fukuda, K. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00960 · Cited by 32
Human-Induced Pluripotent Stem Cells: In Quest of Clinical Applications
Madonna, R. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9504-0 · Cited by 33
Lu, H. R., Hortigon-Vinagre, M. P., Zamora, V., Kopljar, I., Bondt, A. D., Gallacher, D. J., & Smith, G. L. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.05.001 · Cited by 30
Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment
Kadota, S., & Shiba, Y. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1171-3 · Cited by 33
Polak, S., Fijorek, K., Glinka, A., Wiśniowska, B., & Mendyk, A. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.585477 · Cited by 31
Cell Therapy Trials in Congenital Heart Disease
Oh, H. (2017) · Circulation Research · doi:10.1161/circresaha.117.309697 · Cited by 31
Stem cell models as an in vitro model for predictive toxicology
Lynch, S., Pridgeon, C. S., Duckworth, C. A., Sharma, P., Park, B. K., & Goldring, C. E. (2019) · Biochemical Journal · doi:10.1042/bcj20170780 · Cited by 36
Multifaceted applications of nanomaterials in cell engineering and therapy
Chen, H., Zeng, Y. C., Liu, W., Zhao, S., Wu, J., & Du, Y. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.002 · Cited by 30
McGivern, J. V., & Ebert, A. D. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.012 · Cited by 30
A new era of disease modeling and drug discovery using induced pluripotent stem cells
Suh, W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0871-0 · Cited by 34
Selvakumar, D., Reyes, L., & Chong, J. J. H. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01666-9 · Cited by 30
Induced Pluripotent Stem Cells: Progress toward Clinical Translation from Bench to Bedside
Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_40-1 · Cited by 29
Zhu, K., Bao, X., Wang, Y., Lu, T., & Zhang, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113970 · Cited by 31
Rajasingh, S., Thangavel, J., Czirók, A., Samanta, S., Roby, K. F., Dawn, B., & Rajasingh, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134093 · Cited by 29
Wahlestedt, M., Ameur, A., Moraghebi, R., Norddahl, G. L., Sten, G., Woods, N., & Bryder, D. (2014) · Stem Cells · doi:10.1002/stem.1630 · Cited by 30
GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes
Bowman, P. R. T., Smith, G. L., & Gould, G. W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217885 · Cited by 30
Disease modelling using human iPSCs
Chamberlain, S. J. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw209 · Cited by 32
Inhibition of CDK5 Alleviates the Cardiac Phenotypes in Timothy Syndrome
Song, L., Park, S.-H. E., Isseroff, Y., Morikawa, K., & Yazawa, M. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.028 · Cited by 30
LncRNA H19 Suppresses Osteosarcomagenesis by Regulating snoRNAs and DNA Repair Protein Complexes
Xu, A., Huang, M.-F., Zhu, D., Gingold, J. A., Bazer, D. A., Chang, B., Wang, D., Lai, C., Lemischka, I. R., Zhao, R., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.611823 · Cited by 35
Budniatzky, I., & Gepstein, L. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0163 · Cited by 33
Self-citationPulse-Driven Magnetoimpedance Sensor Detection of Cardiac Magnetic Activity
Nakayama, S., Sawamura, K., Mohri, K., & Uchiyama, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025834 · Cited by 28
Trevisan, M., Sinigaglia, A., Desole, G., Berto, A., Pacenti, M., Palù, G., & Barzon, L. (2015) · Viruses · doi:10.3390/v7072800 · Cited by 28
Gating and regulation of KCNH (ERG, EAG, and ELK) channels by intracellular domains
Codding, S. J., Johnson, A. A., & Trudeau, M. C. (2020) · Channels · doi:10.1080/19336950.2020.1816107 · Cited by 29
Pushp, P., Nogueira, D. E. S., Rodrigues, C. A. V., Ferreira, F. C., Cabral, J. M. S., & Gupta, M. K. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10061-2 · Cited by 27
Narkar, A., Willard, J. M., & Blinova, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063199 · Cited by 33
Modeling Long-QT Syndromes with iPS Cells
Sinnecker, D., Goedel, A., Dorn, T., Dirschinger, R. J., Moretti, A., & Laugwitz, K. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9416-1 · Cited by 27
Human Kidney Cell Reprogramming: Applications for Disease Modeling and Personalized Medicine
O’Neill, A. C., & Ricardo, S. D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121199 · Cited by 29
Kuusela, J., Kujala, V. J., Kiviaho, A., Ojala, M., Swan, H., KONTULA, K. K., & Aalto‐Setälä, K. (2016) · SpringerPlus · doi:10.1186/s40064-016-1889-y · Cited by 27
Kurata, Y., Tsumoto, K., Hayashi, K., Hisatome, I., Kuda, Y., & Tanida, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01545 · Cited by 30
Veldhuizen, J., Mann, H. F., Karamanova, N., Horn, W. D. V., Migrino, R. Q., Brafman, D. A., & Nikkhah, M. (2022) · Science Advances · doi:10.1126/sciadv.abq6720 · Cited by 27
Lee, S., Lee, H.-A., Choi, S. W., Kim, S. J., & Kim, K. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.015 · Cited by 27
Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure
Nunes, S. S., Feric, N. T., Pahnke, A., Miklas, J. W., Li, M., Coles, J. G., Gagliardi, M., Keller, G. M., & Radisic, M. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00496 · Cited by 28
New Molecular Scaffolds for Fluorescent Voltage Indicators
Boggess, S. C., Gandhi, S. S., Siemons, B. A., Huebsch, N., Healy, K. E., & Miller, E. W. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b00978 · Cited by 26
Mechanisms underlying epilepsies associated with sodium channel mutations
Steinlein, O. K. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00005-3 · Cited by 28
Induced pluripotent stem cells as a next-generation biomedical interface
Hankowski, K. E., Hamazaki, T., Umezawa, A., & Terada, N. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.85 · Cited by 30
Romano, G., Morales, F., Marino, I. R., & Giordano, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24437 · Cited by 26
Regenerative medicine for the treatment of heart disease
Hansson, E. M., & Lendahl, U. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12033 · Cited by 30
Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?
Bruyneel, A. A. N., McKeithan, W. L., Feyen, D. A. M., & Mercola, M. A. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.07.003 · Cited by 27
Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Paci, M., Penttinen, K., Pekkanen-Mattila, M., & Koivumäki, J. T. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000972 · Cited by 27
Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases
Schreurs, J., Sacchetto, C., Colpaert, R. M. W., Vitiello, L., Rampazzo, A., & Calore, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010985 · Cited by 26
Harnessing the Induction of Cardiomyocyte Proliferation for Cardiac Regenerative Medicine
Sharma, A., Zhang, Y., & Wu, S. M. (2015) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-015-0404-z · Cited by 27
Developmental neurotoxicity screening using human embryonic stem cells
Bosnjak, Z. J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.023 · Cited by 25
Stem cell technology for drug discovery and development
Hook, L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.11.001 · Cited by 25
Integrated Analysis of Drug-Induced Gene Expression Profiles Predicts Novel hERG Inhibitors
Babcock, J. J., Du, F., Xu, K., Wheelan, S. J., & Li, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069513 · Cited by 28
Müller, M., Stockmann, M., Malan, D., Wolheim, A., Tischendorf, M., Linta, L., Katz, S., Lin, Q., Latz, S., Brunner, C., et al. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9324-9 · Cited by 27
Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Bezzerides, V. J., Zhang, D., & Pu, W. T. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-1113 · Cited by 26
The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing
Ye, L., Ni, X., Zhao, Z., Lei, W., & Hu, S. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9811-3 · Cited by 27
Podgurskaya, A. D., Tsvelaya, V. A., Slotvitsky, М. М., Dementyeva, E. V., Valetdinova, K. R., & Игоревич, А. К. (2019) · Cardiovascular Toxicology · doi:10.1007/s12012-019-09532-x · Cited by 26
Sun, Y., Kao, H. K. J., Chang, C.-W., Merleev, A. A., Overton, J. L., Pretto, D. I., Yechikov, S., Maverakis, E., Chiamvimonvat, N., Chan, J. W., et al. (2019) · Stem Cells · doi:10.1002/stem.3085 · Cited by 27
New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models
Sharma, A. K., Singh, S., Bhat, M., Gill, K., Zaid, M., Kumar, S., Shakya, A., Tantray, J., Jose, D., Gupta, R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41942-4 · Cited by 26
Zhi, D., Irvin, M. R., Gu, C. C., Stoddard, A. J., Lorier, R., Matter, A. M., Rao, D. C., Srinivasasainagendra, V., Tiwari, H. K., Turner, A., et al. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00092 · Cited by 25
Ban, K., Wile, B. M., Cho, K.-W., Kim, S., Song, M.-K., Kim, S. Y., Singer, J., Syed, A., Yu, S. P., Wagner, M. B., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.10.021 · Cited by 24
The novel heart-specific RING finger protein 207 is involved in energy metabolism in cardiomyocytes
Mizushima, W., Takahashi, H., Watanabe, M., Kinugawa, S., Matsushima, S., Takada, S., Yokota, T., Furihata, T., Matsumoto, J., Tsuda, M., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.09.013 · Cited by 25
Moreau, A., Mercier, A., Thériault, O., Boutjdir, M., Burger, B., Keller, D. I., & Chahine, M. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.10.001 · Cited by 26
Christidi, E., Huang, H., & Brunham, L. R. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.06.002 · Cited by 26
Silencing of CCR4-NOT complex subunits affects heart structure and function
Elmeń, L., Volpato, C. B., Kervadec, A., Pineda, S. B., Kalvakuri, S., Alayari, N. N., Foco, L., Pramstaller, P. P., Ocorr, K. A., Rossini, A., et al. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.044727 · Cited by 25
Ballan, N., Shaheen, N., Keller, G. M., & Gepstein, L. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.07.006 · Cited by 27
Self-citationCamman, M., Joanne, P., Agbulut, O., & Hélary, C. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.05.040 · Cited by 29
In Vitro Uses of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Matsa, E., & Denning, C. N. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9376-5 · Cited by 26
Modeling heart disease in a dish: From somatic cells to disease-relevant cardiomyocytes
Zanella, F., Lyon, R. C., & Sheikh, F. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.06.002 · Cited by 25
Nakayama, S., Atsuta, S., Shinmi, T., & Uchiyama, T. (2011) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2011.05.041 · Cited by 23
Song, M., Paul, S., Lim, H., Dayem, A. A., & Cho, S. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0205-9 · Cited by 23
Ranolazine: Clinical Applications and Therapeutic Basis
Hawwa, N., & Menon, V. (2013) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-012-0003-2 · Cited by 25
Human induced pluripotent stem cell for modeling cardiovascular diseases
Liang, P., & Du, J. (2014) · Regenerative Medicine Research · doi:10.1186/2050-490x-2-4 · Cited by 28
Mack, D. L., Guan, X., Wagoner, A. L., Walker, S. J., & Childers, M. K. (2014) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000141 · Cited by 25
Cardiac differentiation of human pluripotent stem cells
Jiang, J., Han, P., Zhang, Q., Zhao, J.-M., & Ma, Y. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01528.x · Cited by 23
Goodrow, R. J., Desai, S., Treat, J. A., Panama, B. K., Desai, M., Nesterenko, V. V., & Cordeiro, J. M. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.11.001 · Cited by 24
Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Rampoldi, A., Singh, M., Wu, Q., Duan, M., Jha, R., Maxwell, J. T., Bradner, J. M., Zhang, X., Saraf, A. P., Miller, G. W., et al. (2019) · Toxicological Sciences · doi:10.1093/toxsci/kfz038 · Cited by 25
Jeziorowska, D., Korniat, A., Salem, J., Fish, K. M., & Hulot, J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1064109 · Cited by 24
Early Repolarization Syndrome; Mechanistic Theories and Clinical Correlates
Mercer, B. N., Begg, G. A., Page, S. P., Bennett, C., Tayebjee, M. H., & Mahida, S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00266 · Cited by 24
Cardiovascular science: opportunities for translating research into improved care
Braunwald, E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67541 · Cited by 26
Chen, L., He, Y., Wang, X., Ge, J., & Li, H. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.530 · Cited by 23
Precision medicine for long QT syndrome: patient-specific iPSCs take the lead
Yu, Y., Deschênes, I., & Zhao, M. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.43 · Cited by 24
Tang, L. F. P., Wang, H., Dai, B., Wang, X., Zhou, D., Shen, J., Guo, F., Wang, J., Zhou, J., Wang, H., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.03.016 · Cited by 22
Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies
Beghini, D. G., Horita, S. I. M., Cascabulho, C. M., Alves, L. A., & Henriques‐Pons, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155467 · Cited by 24
Pan, Z., Ebert, A., & Liang, P. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02486-y · Cited by 22
Dynamic Clamp in Electrophysiological Studies on Stem Cell–Derived Cardiomyocytes—Why and How?
Verkerk, A. O., & Wilders, R. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000955 · Cited by 22
Scaffold-based and scaffold-free cardiac constructs for drug testing
Arai, K., Kitsuka, T., & Nakayama, K. (2021) · Biofabrication · doi:10.1088/1758-5090/ac1257 · Cited by 22
Dowaidar, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3nwzd · Cited by 26
Davidson, S. M., Andreadou, I., Antoniades, C. A., Bartúnek, J., Basso, C., Brundel, B. J. J. M., Byrne, R. A., Chiva‐Blanch, G., Martins, P. A. D. C., Evans, P. C., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf023 · Cited by 23
Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
Seah, S., Farran, C. A. E., Warrier, T., Xu, J., & Loh, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226119 · Cited by 28
Chua, C. J., Morrissette-McAlmon, J. B. F., Tung, L., & Boheler, K. R. (2023) · Genes · doi:10.3390/genes14101864 · Cited by 22
The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
Thorrez, L., & Sampaolesi, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797904154 · Cited by 24
Preininger, M. K., Singh, M., & Xu, C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-45457-3_10 · Cited by 22
Hadoux, J., Desterke, C., Féraud, O., Guibert, M., Rose, R. F. D., Opolon, P., Divers, D., Gobbo, E., Griscelli, F., Schlumberger, M. J., et al. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.11.015 · Cited by 21
Giadone, R. M., Rosarda, J. D., Akepati, P. R., Thomas, A. C., Boldbaatar, B., James, M. F., Wilson, A. A., Sanchorawala, V., Connors, L. H., Berk, J. L., et al. (2018) · Amyloid · doi:10.1080/13506129.2018.1489228 · Cited by 21
Gélinas, R., Khoury, N. E., Chaix, M., Beauchamp, C., Alikashani, A., Éthier, N., Boucher, G., Villeneuve, L. R., Robb, L. J., Latour, F., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001755 · Cited by 21
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.